Read the full stored bill text
×
Bill SD.3650
SECTION 1. Section 28 of chapter 32A, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
SECTION 2. Section 10K of Chapter 118E, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
SECTION 3. Section 47W of Chapter 175 of the General Laws, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
SECTION 4. Section 8W of Chapter 176A of the General Laws, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
SECTION 5. Section 4W of Chapter 176B of the General Laws, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
SECTION 6. Section 4O of Chapter 176G of the General Laws, as so appearing in the 2024 Official Edition, is hereby amended by adding, after clause (vi), the following clause:-
“(vii) prescription medications related to the provision of gender affirming health care services, as defined in section 11I½ of chapter 12 intended to last for not more than a 12-month period for any subsequent dispensing of the same prescription, which may be dispensed all at once or over the course of the 12-month period, regardless of whether the covered person was enrolled in the policy at the time the prescription was first dispensed; provided, however, that a corporation shall not be required to provide coverage for more than one 12-month prescription in a single dispensing per plan year.”
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
Close